José Ignacio Chacón

3.4k total citations
63 papers, 750 citations indexed

About

José Ignacio Chacón is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, José Ignacio Chacón has authored 63 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 25 papers in Cancer Research. Recurrent topics in José Ignacio Chacón's work include Breast Cancer Treatment Studies (22 papers), Advanced Breast Cancer Therapies (20 papers) and Cancer Treatment and Pharmacology (18 papers). José Ignacio Chacón is often cited by papers focused on Breast Cancer Treatment Studies (22 papers), Advanced Breast Cancer Therapies (20 papers) and Cancer Treatment and Pharmacology (18 papers). José Ignacio Chacón collaborates with scholars based in Spain, United States and Russia. José Ignacio Chacón's co-authors include Lourdes Calvo, Aňa Lluch, Joan Albanell, Eva Carrasco, Emilio Alba, José Antonio López García‐Asenjo, Arrate Plazaola, Juan de la Haba-Rodríguez, Pedro Sánchez‐Rovira and Marisol Mateo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

José Ignacio Chacón

57 papers receiving 732 citations

Peers

José Ignacio Chacón

ONCOL

PFM

PRM

GENET

Dìlek Dìnçol Türkiye

Eunyoung Lee South Korea

Joan Francesc Julián Ibáñez Spain

J. Sundberg Sweden

José Muñoz-Langa Spain

Umut Kefeli Türkiye

J Hermans Netherlands

A. Galid Austria

Paulo Kauffman Brazil

Carol D. Burk United States

Dìlek Dìnçol Türkiye

José Ignacio Chacón

143 ×0.3

ONCOL

46 ×0.1

79 ×0.4

PFM

105 ×0.5

PRM

36 ×0.3

GENET

Citations per year, relative to José Ignacio Chacón José Ignacio Chacón (= 1×) peers Dìlek Dìnçol

Countries citing papers authored by José Ignacio Chacón

Since Specialization

Citations

This map shows the geographic impact of José Ignacio Chacón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Ignacio Chacón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Ignacio Chacón more than expected).

Fields of papers citing papers by José Ignacio Chacón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Ignacio Chacón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Ignacio Chacón. The network helps show where José Ignacio Chacón may publish in the future.

Co-authorship network of co-authors of José Ignacio Chacón

This figure shows the co-authorship network connecting the top 25 collaborators of José Ignacio Chacón. A scholar is included among the top collaborators of José Ignacio Chacón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Ignacio Chacón. José Ignacio Chacón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martínez-Jáñez, Noelia, Meritxell Bellet, Fernando Henao, et al.. (2024). First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN. Breast Cancer Research and Treatment. 206(2). 317–328. 4 indexed citations

Martínez-Jáñez, Noelia, Fernando Henao, Luís Manso, et al.. (2023). Abstract P4-01-28: PALBOSPAIN: OBSERVATIONAL ANALYSIS OF FIRST-LINE THERAPY WITH PALBOCICLIB IN PATIENTS WITH HR+/HER2- METASTATIC BREAST CANCER (MBC) IN REAL-LIFE CONDITIONS. Cancer Research. 83(5_Supplement). P4–1. 3 indexed citations

Escudero‐Vilaplana, Vicente, et al.. (2021). Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study. International Journal of Environmental Research and Public Health. 18(2). 394–394. 5 indexed citations

Ribelles, Nuria, Isabel Álvarez, Àngels Arcusa, et al.. (2021). Electronic health records and patient registries in medical oncology departments in Spain. Clinical & Translational Oncology. 23(10). 2099–2108. 3 indexed citations

Chacón, José Ignacio, et al.. (2020). Actividad asistencial y motivos de consulta en las guardias de medicina interna en un hospital de tercer nivel. SHILAP Revista de lepidopterología. 3(6). 100154–100154.

González-Santiago, Santiago, Cristina Saura, Eva Ciruelos, et al.. (2020). Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study). Breast Cancer Research and Treatment. 184(2). 469–479. 15 indexed citations

Ciruelos, Eva, Álvaro Montaño, César A. Rodríguez, et al.. (2020). Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2‐positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012‐07). European Journal of Cancer Care. 29(4). e13253–e13253. 7 indexed citations

Martín, Miguel, Ángel Guerrero‐Zotano, Á. Montero, et al.. (2020). GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain. The Oncologist. 25(9). e1339–e1345. 10 indexed citations

Chacón, José Ignacio, Luis de la Cruz‐Merino, Joaquín Gavilá Gregori, et al.. (2019). SEOM clinical guidelines in advanced and recurrent breast cancer (2018). Clinical & Translational Oncology. 21(1). 31–45. 13 indexed citations

10.

Muñoz-Mateu, Montserrat, Luis de la Cruz‐Merino, Lourdes Calvo, et al.. (2019). Development and validation of a sexual relations satisfaction scale in patients with breast cancer — “SEXSAT-Q”. Health and Quality of Life Outcomes. 17(1). 143–143. 6 indexed citations

11.

Redondo, Andrés, Manuel Ramos Vázquez, Luís Manso, et al.. (2018). Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational “LORENA” study. OncoTargets and Therapy. Volume 11. 5845–5852. 5 indexed citations

12.

Chacón, José Ignacio, et al.. (2018). Socioeducational factors associated to the perception of mistreatment in peruvian medical students. Americanae (AECID Library). 1 indexed citations

13.

Ruíz‐Borrego, Manuel, M. Martín Jiménez, A. Ruíz, et al.. (2017). Phase III evaluating the addition of fulvestrant (F) to anastrozol (A) as adjuvant therapy in postmenopausal women with hormone receptor positive HER2 negative (HR+/HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study. Annals of Oncology. 28. v43–v43. 4 indexed citations

14.

Martín, Miguel, Moshe Inbar, Eva Carrasco, et al.. (2015). Phase III study of Palbociclib in combination with Exemestane vs. Capecitabine, in Hormonal Receptor (HR) positive/HER2 negative Metastatic Breast Cancer (MBC) patients with Resistance to non-steroidal Aromatase inhibitors (NSAI): PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006). Journal of Clinical Oncology. 1 indexed citations

15.

Alés‐Martínez, José E., A. Ruíz, José Ignacio Chacón, et al.. (2014). Preventive treatments for breast cancer: recent developments. Clinical & Translational Oncology. 17(4). 257–263. 8 indexed citations

16.

Alba, Emilio, Lourdes Calvo, Joan Albanell, et al.. (2012). Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study. Annals of Oncology. 23(12). 3069–3074. 147 indexed citations

17.

Alba, Emilio, José Ignacio Chacón, Aňa Lluch, et al.. (2012). A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study. Breast Cancer Research and Treatment. 136(2). 487–493. 101 indexed citations

18.

Chacón, José Ignacio, et al.. (1997). Treatment of Superior and Inferior Vena Cava Syndromes of Malignant Cause with Wallstent Catheter Placed Percutaneously. American Journal of Clinical Oncology. 20(3). 293–297. 22 indexed citations

19.

Feliú, Jaime, José Ignacio Chacón, Enrique Espinosa, et al.. (1996). Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen. Cancer Chemotherapy and Pharmacology. 38(2). 191–194. 4 indexed citations

20.

Barón, Manuel González, José Ignacio Chacón, Carlos García Girón, et al.. (1991). Antiemetic Regimens in Outpatients Receiving Cisplatin and Non-Cisplatin Chemotherapy: A Randomized Trial Comparing High-Dose Metoclopramide Plus Methylprednisolone with and Without Lorazepam. Acta Oncologica. 30(5). 623–627. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact